55585-92-7

Basic information

• Product Name: N-acetyl-DL-homocysteine
• Synonyms: N-acetyl-DL-homocysteine
• CAS NO: 55585-92-7
• Molecular Formula: C₆H₁₁NO₃S
• Molecular Weight: 177.22144
• EINECS: 259-713-2
• Mol File: 55585-92-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 434.3°Cat760mmHg
• Flash Point: 216.5°C
• Appearance: /
• Density: 1.243g/cm³
• Vapor Pressure: 9.26E-09mmHg at 25°C
• Refractive Index: 1.513
• PKA: 3.50±0.10(Predicted)
• CAS DataBase Reference: N-acetyl-DL-homocysteine(CAS DataBase Reference)
• NIST Chemistry Reference: N-acetyl-DL-homocysteine(55585-92-7)
• EPA Substance Registry System: N-acetyl-DL-homocysteine(55585-92-7)

Safety Data

• Hazardous Substances Data: 55585-92-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C6H11NO3S/c1-4(8)7-5(2-3-11)6(9)10/h5,11H,2-3H2,1H3,(H,7,8)(H,9,10)/t5-/m0/s1

Upstream product

• 5545-17-5 N,N'-bis(acetyl)cystine 
• 1195-16-0 N-acetyl-DL-homocysteinethiolactone 
• 108-24-7 acetic anhydride 
• 41442-22-2 L-methionine sodium salt 
• 348-67-4 D-methionine 

Downstream Products

• 93428-83-2 N-acetyl-L-methionine anilide 
• 1509-92-8 N-acetyl-D-methionine 
• 63-68-3 L-methionine 
• 348-67-4 D-methionine 

Relevant articles and documents

Mechanism-based inhibition of an essential bacterial adenine DNA methyltransferase: Rationally designed antibiotics [1]

-

PHARMACEUTICAL COMBINATIONS INCLUDING ANTI-INFLAMMATORY AND ANTIOXIDANT CONJUGATES USEFUL FOR TREATING METABOLIC DISORDERS

One aspect of the present invention is a pharmaceutical combination comprising (a) an anti-inflammatory agent/anti-oxidant agent conjugate; and (b) an insulin secretogogue, an insulin sensitizer, an alpha-glucosidase inhibitor, a peptide analog, or a combination thereof. Another aspect of the invention relates to methods of treating metabolic disorders with such conjugates.

DNA Methyltransferase inhibitors

A compound of the formula or a pharmaceutically acceptable salt thereof,whereinR1, R2, and R3 are the same or different and are independently hydrogen, lower alkyl, aryl or substituted aryl, lower alkoxy, lower alkoxyalkyl, or cycloalkyl or cycloalkyl alkoxy, where each cycloalkyl group has from 3-7 members, where up to two of the cycloalkyl members are optionally hetero atoms selected from oxygen and nitrogen, and where any member of the alkyl, aryl or cycloalkyl group is optionally substituted with halogen, lower alkyl or lower alkoxy, aryl or substituted aryl, andwhereR3 can be ribose, deoxyribose or phosphorylated derivatives thereof,whereinR1, R2, and R3 are not all hydrogen andwhereinwhen R3 is ribose, deoxyribose or phosphorylated derivatives thereof, one of R1 or R2 is not hydrogen.